Ethnic Diversity in Infant Gut Microbiota is Apparent Before the Introduction of Complementary Diets

Jia Xu,Blair Lawley,Gerard Wong,Anna Otal,Li Chen,Toh Jia Ying,Xinyi Lin,Wei,Fabian Yap,Yap-Seng Chong,Peter D. Gluckman,Yung Seng Lee,Mary Foong-Fong Chong,Gerald W. Tannock,Neerja Karnani
DOI: https://doi.org/10.1080/19490976.2020.1756150
IF: 12.2
2020-01-01
Gut Microbes
Abstract:The human gut microbiota develops soon after birth and can acquire inter-individual variation upon exposure to intrinsic and environmental cues. However, inter-individual variation has not been comprehensively assessed in a multi-ethnic study. We studied a longitudinal birth cohort of 106 infants of three Asian ethnicities (Chinese, Malay, and Indian) that resided in the same geographical location (Singapore). Specific and temporal influences of ethnicity, mode of delivery, breastfeeding status, gestational age, birthweight, gender, and maternal education on the development of the gut microbiota in the first 2 years of life were studied. Mode of delivery, breastfeeding status, and ethnicity were identified as the main factors influencing the compositional development of the gut microbiota. Effects of delivery mode and breastfeeding status lasted until 6M and 3M, respectively, with the primary impact on the diversity and temporal colonization of the genera Bacteroides and Bifidobacterium. The effect of ethnicity was apparent at 3M post-birth, even before the introduction of weaning (complementary) foods, and remained significant after adjusting for delivery mode and breastfeeding status. Ethnic influences remained significant until 12M in the Indian and Chinese infants. The microbiota of Indian infants was characterized by higher abundances of Bifidobacterium and Lactobacillus, while Chinese infants had higher abundances of Bacteroides and Akkermansia. These findings provide a detailed insight into the specific and temporal influences of early life factors and ethnicity in the development of the human gut microbiota. Trial Registration: Clinicaltrials.gov registration no. NCT01174875.
What problem does this paper attempt to address?